Search results for: Jorge Mestre-Ferrandiz
Filter search results
How Does Pharmaceutical Spending Drive Innovation in Europe?
7 February 2022
…Health Policy, 19(2), pp.217–229. 10.1007/s40258-020-00601-9. Berdud, M., Drummond, M. and Towse, A., 2020. Establishing a reasonable price for an orphan drug. Cost Effectiveness and Resource Allocation, 18(1), p.31. 10.1186/s12962-020-00223-x. Mestre-Ferrandiz,…
Accounting for Preference Heterogeneity in Discrete Choice Experiments
4 May 2022
…Hampson, G., Llewelyn, M. J., Mestre-Ferrandiz, J., & Hopkins, M. M. (2020). A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance. Applied Health Economics and…
Projecting Expenditure on Medicines in the NHS
4 January 2013
…and can be downloaded from: http://link.springer.com/article/10.1007%2Fs40273-013-0082-1 Please cite as: O’Neill, P., Mestre-Ferrandiz, J., Puig-Peiro, R. and Sussex, J., 2013. Projecting Expenditure on Medicines in the UK NHS. PharmacoEconomics, 31(10), pp.933-957….
Data Governance Arrangements for Real-World Evidence: South Korea
1 September 2017
…“ideal”, facilitative framework for data governance. 1 Cole, A., Garrison, L., Mestre-Ferrandiz, J., & Towse, A. (2015). Data Governance Arrangements for Real-World Evidence. OHE Consulting Report, London: Office of Health…
The Economics of Antibiotics – Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment Model to Tackle Antimicrobial Resistance
12 October 2022
…Research Paper. Available from https://www.ohe.org/publications/hta-and-payment-mechanisms-new-drugs-tackle-amr. Ferraro, J., Towse, A., and Mestre-Ferrandiz, J. (2017) Incentives for New Drugs to Tackle Anti-Microbial Resistance. OHE Briefing. Available from https://www.ohe.org/publications/incentives-new-drugs tackle-anti-microbial-resistance. Sharma, P. and…
The Economics of Antibiotics – Part 2: Value Assessment within the NICE-NHS AMR Pilot
12 October 2022
…to 2024. Available at: https://www.gov.uk/government/publications/uk-5-year-action-plan-for-ant…. [Accessed September 2022]. Karlsberg Schaffer, S., West, P., Towse, A., Henshall, C., Mestre-Ferrandiz, J., Masterson, R. and Fischer, A., 2017. Additional Elements of Value for…
Can a continued focus on prevention, diagnosis, and treatment see the NHS to another 75 years?
27 July 2023
…in Cancer Treatment – OHE Hawe, E. (2009) Compendium of Health Statistics. OHE Monograph. Available from https://www.ohe.org/publications/compendium-health-statistics / Compendium of Health Statistics – OHE Mestre-Ferrandiz, J., Mordoh, A. and Sussex,…
The Dynamics of Drug Shortages
9 January 2024
…G., Mestre-Ferrandiz, J., Pana, A., Perelman, J., Yfantopoulos, J. and Simoens, S., 2023. New pricing models for generic medicines to ensure long-term sustainable competition in Europe. Frontiers in Pharmacology, [online]…